{
  "trial_id": "NCT02214017",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, living situation, ability to communicate by videotelephone, psychiatric history, type of diabetes, speech ability, language proficiency, renal function (GFR), liver function, cancer treatment status, ability to administer medication.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "duration of type 2 diabetes",
          "type of diabetes"
        ],
        [
          "renal function (GFR)",
          "renal function (GFR)"
        ],
        [
          "liver insufficiency",
          "liver function"
        ],
        [
          "cancer treatment status",
          "cancer treatment status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "BMI",
        "insulin treatment"
      ],
      "remaining_candidate_features": [
        "living situation",
        "ability to communicate by videotelephone",
        "psychiatric history",
        "speech ability",
        "language proficiency",
        "ability to administer medication."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Blood Pressure, Cholesterol, Triglycerides, GFR,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "duration of type 2 diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "insulin treatment"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Baseline HbA1c",
        "Blood Pressure",
        "Cholesterol",
        "Triglycerides",
        "GFR"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes duration, Glycated hemoglobin, Blood pressure, Body Mass Index, Previous cardiovascular disease (CVD) event,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "BMI",
          "Body Mass Index"
        ],
        [
          "duration of type 2 diabetes",
          "Diabetes duration"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race and Ethnicity Not Collected",
        "insulin treatment"
      ],
      "remaining_candidate_features": [
        "Glycated hemoglobin",
        "Blood pressure",
        "Previous cardiovascular disease (CVD) event"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), duration of diabetes, HbA1c at baseline, systolic blood pressure, diastolic blood pressure, smoking status, comorbidities (heart failure, lung insufficiency, renal disease, liver disease, cancer), medication use (antidiabetic agents, antihypertensive agents, lipid-lowering agents), education level, occupation, living situation (alone or with others).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "duration of type 2 diabetes",
          "duration of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race and Ethnicity Not Collected",
        "Region of Enrollment",
        "insulin treatment"
      ],
      "remaining_candidate_features": [
        "HbA1c at baseline",
        "systolic blood pressure",
        "diastolic blood pressure",
        "smoking status",
        "comorbidities (heart failure, lung insufficiency, renal disease, liver disease, cancer)",
        "medication use (antidiabetic agents, antihypertensive agents, lipid-lowering agents)",
        "education level",
        "occupation",
        "living situation (alone or with others)"
      ]
    }
  }
}